142 related articles for article (PubMed ID: 9399620)
1. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient.
Cox TH; Baillie GM; Baliga P
Pharmacotherapy; 1997; 17(6):1328-30. PubMed ID: 9399620
[TBL] [Abstract][Full Text] [Related]
2. Sublingual administration of tacrolimus in a renal transplant patient.
Romero I; Jiménez C; Gil F; Escuin F; Ramirez E; Fudio S; Borobia A; Carcas A
J Clin Pharm Ther; 2008 Feb; 33(1):87-9. PubMed ID: 18211623
[TBL] [Abstract][Full Text] [Related]
3. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient.
Hernández G; Jiménez C; Arriba L; Moreno E; Lucas M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):526-31. PubMed ID: 11709689
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-related polyneuropathy: case report and review of the literature.
De Weerdt A; Claeys KG; De Jonghe P; Ysebaert D; Chapelle T; Roeyen G; Jorens PG
Clin Neurol Neurosurg; 2008 Mar; 110(3):291-4. PubMed ID: 18055100
[TBL] [Abstract][Full Text] [Related]
5. Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases.
Bassily-Marcus A; Kohli-Seth R; Leibowitz A; Murgolo V; Oropello J; Manasia A; Benjamin E
Exp Clin Transplant; 2008 Mar; 6(1):80-3. PubMed ID: 18405250
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
Toth CC; Burak K; Becker W
Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
[TBL] [Abstract][Full Text] [Related]
7. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
8. Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report.
Kelley M; Jain A; Kashyap R; Orloff M; Abt P; Wrobble K; Venkataramanan R; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3165-7. PubMed ID: 16213338
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
10. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients.
Karasu Z; Gurakar A; Carlson J; Pennington S; Kerwin B; Wright H; Nour B; Sebastian A
J Okla State Med Assoc; 2001 Apr; 94(4):121-3. PubMed ID: 11392178
[TBL] [Abstract][Full Text] [Related]
11. Miller fisher variant of guillain-barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation.
Kaushik P; Cohen AJ; Zuckerman SJ; Vatsavai SR; Pepper JS; Banda VR; Eason JD; Loss GE; Kaushik R
Ann Pharmacother; 2005 Jun; 39(6):1124-7. PubMed ID: 15855240
[TBL] [Abstract][Full Text] [Related]
12. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P
Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppression and the problems in partial liver transplantation].
Kawasaki M; Hashikura Y; Matsunami H; Makunouchi M
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):683. PubMed ID: 8963785
[No Abstract] [Full Text] [Related]
14. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
[TBL] [Abstract][Full Text] [Related]
15. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
16. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
17. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
19. Sudden hearing loss associated with tacrolimus in a liver transplant recipient.
Norman K; Bonatti H; Dickson RC; Aranda-Michel J
Transpl Int; 2006 Jul; 19(7):601-3. PubMed ID: 16764642
[No Abstract] [Full Text] [Related]
20. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: A single-center experience at the University of Tokyo.
Tamura S; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Murai N; Makuuchi M
Transplant Proc; 2004 Dec; 36(10):3242-4. PubMed ID: 15686738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
